Login to Your Account

Clinic Roundup

Friday, August 12, 2011
• Lexicon Pharmaceuticals Inc., of The Woodlands, Texas, published Phase II data showing LX1031 was well tolerated and provided relief from pain and discomfort in non-constipating irritable bowel syndrome. The data were published in Gastroenterology. LX1031 is a tryptophan hydroxylase inhibitor.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription